IntegraMed America to Provide Full Marketing Support to Reproductive Medicine Associates of New Jersey

Agreement Marks First Sale of New FertilityMarkit(TM) Program

Mar 25, 2002, 00:00 ET from Reproductive Medicine Associates of New Jersey

    PURCHASE, N.Y., March 25 /PRNewswire-FirstCall/ --
 IntegraMed America, Inc. (Nasdaq:   INMD) today announced the signing of a
 marketing contract with Reproductive Medicine Associates of New Jersey
 (RMANJ).  Under the terms of the agreement, IntegraMed will provide full
 marketing support to help RMANJ, which performed an estimated 2000 in vitro
 fertilization procedures during 2001, reach a new level of growth and
 development for its state-of-the-art fertility center.
     Simultaneous to announcing the new contract, IntegraMed also announced
 that its award-winning marketing programs are now being offered as
 FertilityMarkit(TM) on a market-exclusive basis to qualified fertility centers
 across the country.
     "Reproductive Medicine Associates of New Jersey is the first fertility
 center outside our core network of Reproductive Science Centers to contract
 with us for the FertilityMarkit program," said Gerardo Canet, President and
 CEO of IntegraMed America, Inc.  "As a leader in the New Jersey marketplace,
 RMANJ is in an excellent position to benefit from our comprehensive marketing
 support, and we are looking forward to bringing the proven power of this
 program to the benefit of RMANJ."
     "Our practice has grown steadily over the last five years," said Michael
 R. Drews, MD, Reproductive Medicine Associates of New Jersey.  "However, we
 reached a point where it seemed prudent to bring marketing and business
 development professionals in to help us organize the effort more
 professionally.  Based on our relationship with IntegraMed and the track
 record they have achieved at their core network of Reproductive Science
 Centers, we are confident they can provide us with a valuable service that
 will help us to achieve our goals."
     "My partners and I have maintained a very positive and productive working
 relationship with IntegraMed over the years," said Richard Scott, MD,
 Reproductive Medicine Associates of New Jersey.  "In our dealings with the
 Company we have consistently found them to be direct, honest and above board.
 They consistently deliver what they promise and have helped us in many ways
 big and small over the years."
     Mr. Canet added, "Historically, IntegraMed has offered a full portfolio of
 services to fertility centers as a comprehensive, integrated package.  Over
 the years we have received many requests from prominent fertility centers to
 "unbundle" our offering so they can contract with us for the specific services
 they need.  During the past year we worked hard to respond to these requests,
 and we are excited to offer our full marketing support on a stand-alone basis
 to qualified fertility centers under the FertilityMarkit brand.  We are proud
 to add FertilityMarkit to our growing menu of "unbundled" offerings that now
 includes FertilityDirect(TM), an Internet-based patient recruitment program;
 ArtWorks Stats(TM), a fertility laboratory information system;
 FertilityLab(TM), an outsourced laboratory director and operations service;
 and, FertilityWeb(TM), a Web site management technology."
     IntegraMed's network of Reproductive Science Centers are among the leaders
 both within their respective markets and nationally.  According to data
 published by the Society of Assisted Reproductive Medicine, IntegraMed's core
 network of Reproductive Science Centers generate, on average, more than five
 times the procedures of the average fertility center while growing more than
 three times as fast as the industry as a whole.  Now, qualified fertility
 centers across the country can gain access to the proven marketing and
 practice development programs that helped IntegraMed's network to achieve
 these outstanding results.
     Fertility centers that contract for FertilityMarkit benefit from
 IntegraMed's ongoing investment in sophisticated, proven marketing programs.
 These award-winning programs can be customized for use by qualified fertility
 centers to ensure they are appropriate for a designated marketplace.  Working
 directly with IntegraMed's Director of Client Services Development, contracted
 fertility centers receive a customized strategic marketing plan, recruiting
 and training for a full time practice development staff member, access to
 IntegraMed's library of collateral material and full support implementing a
 proven program for growth and development.
     Reproductive Medicine Associates of New Jersey was founded by Paul A.
 Bergh, MD, Michael R. Drews, MD and Richard T. Scott, Jr. MD, all board
 certified in reproductive endocrinology.  Based in Morristown, NJ, RMANJ is a
 full-service infertility and assisted reproductive technology practice with
 satellite offices in West Orange, Englewood and Summerset, NJ.  Today, RMANJ
 is comprised of 12 physicians and 110 staff, and has among the highest success
 rates for fertility treatment in the country.
     IntegraMed America, Inc. provides services to medical practices
 specializing in infertility and assisted reproductive technology.  These
 services include finance, administration, information systems and marketing.
 The Company also operates a mail-order pharmacy that distributes fertility
 medication to patients and offers treatment-financing programs for self-pay
     Statements contained in this press release that are not based on
 historical fact, including statements concerning future results, performance,
 expectations and expansion of IntegraMed America are forward-looking
 statements.  Actual results may differ materially from the statements made as
 a result of various factors including, but not limited to, the risks
 associated with the Company's ability to finance future growth; the loss of
 significant management contract(s); profitability at Reproductive Science
 Centers managed by IntegraMed America; changes in insurance coverage,
 government laws and regulations regarding health care or managed care
 contracting; and other risks, including those identified in the Company's most
 recent Form 10-K and in other documents filed by the Company with the U.S.
 Securities and Exchange Commission (SEC).
                     MAKE YOUR OPINION COUNT -  Click Here

SOURCE Reproductive Medicine Associates of New Jersey